Medivation Inc (MDVN)

MDVN (NASDAQ:Drugs) EQUITY
$81.44
pos +0.02
+0.02%
Today's Range: 81.43 - 81.48 | MDVN Avg Daily Volume: 4,328,800
Last Update: 09/27/16 - 4:14 PM EDT
Volume: 7,203,016
YTD Performance: 0.00%
Open: $81.44
Previous Close: $81.42
52 Week Range: $26.41 - $63.35
Oustanding Shares: 165,928,674
Market Cap: 13,513,231,211
6-Month Chart
TheStreet Ratings Grade for MDVN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 2 3 9 9
Moderate Buy 0 0 0 0
Hold 11 11 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.69 2.57 1.62 1.62
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
MDVN Sector Avg. S&P 500
0.00 54.10 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue 32.80 4.20 0.72
Net Income -11.50 -6.90 0.00
EPS -14.00 -6.50 0.00
Earnings for MDVN:
EBITDA 0.41B
Revenue 0.94B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $0.30 $0.43 $1.00 $1.56
Number of Analysts 4 4 5 1
High Estimate $0.33 $0.50 $1.11 $1.56
Low Estimate $0.25 $0.31 $0.83 $1.56
Prior Year $0.27 $0.21 $0.68 $1.00
Growth Rate (Year over Year) 10.19% 103.57% 46.76% 56.31%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Anders Keitz

 | Aug 24, 2016 | 5:27 PM EDT
Pfizer's second acquisition this week could add risk. Some retailers attract portfolio managers.
By

James "Rev Shark" DePorre

 | Aug 22, 2016 | 4:21 PM EDT
Stocks travel a good distance just to end up nowhere.
By

Bret Jensen

 | Aug 22, 2016 | 4:16 PM EDT
It was nice to fill in for Doug Kass on what was a very uneventful Monday to begin the week. The market traded in an extremely narrow range for the day, and outside the strength in biotech and the weakness in oil after a nice recent rally there really wasn't much of note that happened today. Still, there were some good conversations on the Daily Dairy despite the directionless market.
By

Bret Jensen

 | Aug 22, 2016 | 2:51 PM EDT
Markets continue to trade in a very narrow range and remain largely directionless.
RMPIA
By

Jim Cramer

 | Aug 22, 2016 | 1:36 PM EDT
That's the hot spot in M&A right now.
RMPIA
By

Bret Jensen

 | Aug 22, 2016 | 11:48 AM EDT
Stocks are back to flat to slightly lower overall, but biotechs are up some 1.5% following the announcement from Pfizer (PFE) of plans to buy Medivation (MDVN) for $14 billion.
By

James "Rev Shark" DePorre

 | Aug 22, 2016 | 10:40 AM EDT
Overall, this is still a good environment for stock picking.
RMPIA
By

Bret Jensen

 | Aug 22, 2016 | 10:31 AM EDT
Las Vegas Sands (LVS) continues to show strength after Bank of America/Merrill Lynch put out an optimistic note this morning about Macau gambling. Energy is weak in early trading. Oil has drifted back down to around $47 a barrel following its recent roughly 20% rally.
By

Anders Keitz

 | Aug 22, 2016 | 8:13 AM EDT
Pfizer agrees to acquire Medivation while Citi puts Foot Locker and Under Armour on the back-to-school shopping list.
RMPIA
By

Bret Jensen

 | Aug 22, 2016 | 7:54 AM EDT
Good morning, Bret Jensen here! It's good to be standing in for Doug Kass again on the daily diary as we begin a new trading week.
On Wednesday of last week NFLX appeared headed for a deep breakdown.  The stock fell ...
We added this one Monday and mentioned it Tuesday right here in CC, we'll take it off the ...
The market is rebounding nicely after yesteday's sell-off.  Biotech has recaptured ha...
The Federal Reserve has made it relatively clear that they intend to raise interest rates...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.